Naltrexone

dopamine receptor D2 ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33236485 Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study. 2021 Mar 1